Stockscreener 앱 받기
564.81
0.96%
-5.46
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
United Therapeutics' Strong Competitive Edge and Robust Cash Flow Indicate a Sustainable Value Opportunity - Bitget
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock - MarketBeat
Allspring Global Investments Holdings LLC Has $52.05 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win (UTHR) - Seeking Alpha
United Therapeutics Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics (NASDAQ: UTHR) CFO exercises options and sells 10k shares - Stock Titan
UNITED THERAPEUTICS (UTHR) director exercises options and sells 1,300 shares under 10b5-1 plan - Stock Titan
UNITED THERAPEUTICS (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan
Wells Fargo Raises Price Target for United Therapeutics (UTHR) t - GuruFocus
United Therapeutics (NASDAQ:UTHR) Price Target Raised to $660.00 at HC Wainwright - MarketBeat
United Therapeutics (UTHR): Analyst Greg Harrison Raises Price T - GuruFocus
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo - 24/7 Wall St.
Retirement Systems of Alabama Has $47.39 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last? - Yahoo Finance
United Therapeutics (UTHR) Achieves Key Milestone in IPF Treatme - GuruFocus
United Therapeutics (UTHR) Sees Positive Results in TETON-1 Stud - GuruFocus
United Therapeutics (UTHR) Tyvaso Shows Promising Results in TET - GuruFocus
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
United Therapeutics (UTHR) Stock Surges Over 12% - GuruFocus
United Therapeutics (UTHR) Surges Nearly 12% - GuruFocus
Why United Therapeutics (UTHR) Stock Is Up Today - Yahoo Finance
UTHR: TD Cowen Raises United Therapeutics Price Target to $660 | - GuruFocus
United Therapeutics Announces Successful Tyvaso Trial - National Today
United Therapeutics (NASDAQ: UTHR) proposed sale of 1,300 shares via option - Stock Titan
United Therapeutics Stock Surges Due to Positive Phase 3 Trial Results - timothysykes.com
United Therapeutics Corp (UTHR) Stock Price Quote Today & Current Price Chart - Capital.com
United Therapeutics Rises on Positive Study for Cornerstone Drug. Why Shares Could Run Even Higher. - Barron's
U.S. Indexes Ended Monday Mixed As United Therapeutics Led, Sysco Lagged - Barron's
United Therapeutics Surges Amid Successful Phase 3 Trials - timothysykes.com
Ralinepag Clinical Trials Propel United Therapeutics Stock Soaring - StocksToTrade
Stocks Rise As Powell's Remarks Cool Rate Fears: What's Moving Markets Monday? - Benzinga
United Therapeutics’ Nebulized Tyvaso Achieves Primary Endpoint in TETON-1 Study for Idiopathic Pulmonary Fibrosis, Outperforming Placebo and TETON-2 Results 12 - Minichart
United Therapeutics Corp (UTHR) Stock Price Up 13.08% on Mar 30 - GuruFocus
United’s Tyvaso nails endpoints in second phase III IPF trial - BioWorld MedTech
Jefferies raises United Therapeutics stock price target on IPF data By Investing.com - Investing.com India
BofA raises United Therapeutics stock price target on trial data By Investing.com - Investing.com Australia
BofA raises United Therapeutics stock price target on trial data - Investing.com
Jefferies raises United Therapeutics stock price target on trial data By Investing.com - Investing.com Australia
United Therapeutics shares surge after positive IPF trial results - ca.finance.yahoo.com
Jefferies raises United Therapeutics stock price target on IPF data - Investing.com
Jefferies raises United Therapeutics stock price target on trial data - Investing.com
United Therapeutics jumps 14.9% as investors refocus on big buyback and positive ralinepag Phase 3 readout - Quiver Quantitative
UNITED THERAPEUTICS CORPORATION (UTHR) - MSN
United Therapeutics (NASDAQ:UTHR) Shares Gap Up Following Analyst Upgrade - MarketBeat
United Therapeutics Tyvaso IPF Success Adds New Layer To Valuation Story - simplywall.st
Why Is United Therapeutics Stock Soaring Monday? - Benzinga
United Therapeutics (NASDAQ:UTHR) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
TD Cowen raises United Therapeutics stock price target on trial win - Investing.com India
Morgan Stanley reiterates United Therapeutics stock rating on trial success By Investing.com - Investing.com India
Jefferies reiterates Buy on United Therapeutics stock after IPF trial By Investing.com - Investing.com South Africa
Morgan Stanley reiterates United Therapeutics stock rating on trial success - Investing.com
1.39%
자본화:
|
볼륨(24시간):